Register Login

Summit Plc (SMMT)

(10% Negative) Summit Therapeutics Inc. (SMMT) Announces Delay in Investors Development Timeline Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Oct. 22, 2025, 12:58 p.m.

    📋 Summit Therapeutics Inc. (SMMT) - Clinical Trial Update

    Filing Date: 2025-10-22

    Accepted: 2025-10-22 08:56:44

    Event Type: Clinical Trial Update

    Event Details:

    Summit Plc (SMMT) Announces Clinical Trial Update Summit Plc (SMMT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: Investors, Investor
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment, Regulatory Process
    • Collaboration: the Company’s Board of Directors
    • Updated Timeline: Tuesday, October 21, 2025, October 22, 2025

    🔬 Clinical Development Pipeline (Summit Therapeutics Inc.):

    Product Type Development Stage Therapeutic Area Source
    Ivonescimab BIOLOGICAL Phase PHASE2 Thymus Carcinoma ClinicalTrials.gov
    AK112 DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Questionnaire Administration OTHER Phase PHASE2 Thymus Carcinoma ClinicalTrials.gov
    Magnetic Resonance Imaging PROCEDURE Phase PHASE2 Thymus Carcinoma ClinicalTrials.gov
    Computed Tomography PROCEDURE Phase PHASE2 Thymus Carcinoma ClinicalTrials.gov
    Biospecimen Collection PROCEDURE Phase PHASE2 Thymus Carcinoma ClinicalTrials.gov
    Biopsy Procedure PROCEDURE Phase PHASE2 Thymus Carcinoma ClinicalTrials.gov
    Surgical Procedure PROCEDURE Phase PHASE2 Advanced Head and Neck Squamous Cell Carcinoma ClinicalTrials.gov
    Positron Emission Tomography PROCEDURE Phase PHASE2 Advanced Head and Neck Squamous Cell Carcinoma ClinicalTrials.gov
    5-fluorouracil DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Leucovorin DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Irinotecan DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Capecitabine DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Oxaliplatin DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    AK117 DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Summit Plc
    • CIK: 0001599298
    • Ticker Symbol: SMMT
    • Period End Date: 2025-10-21
    • Document Type: 8-K

Search

News categories